Your browser doesn't support javascript.
loading
Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis.
Wu, Yin; Levis, Brooke; Riehm, Kira E; Saadat, Nazanin; Levis, Alexander W; Azar, Marleine; Rice, Danielle B; Boruff, Jill; Cuijpers, Pim; Gilbody, Simon; Ioannidis, John P A; Kloda, Lorie A; McMillan, Dean; Patten, Scott B; Shrier, Ian; Ziegelstein, Roy C; Akena, Dickens H; Arroll, Bruce; Ayalon, Liat; Baradaran, Hamid R; Baron, Murray; Bombardier, Charles H; Butterworth, Peter; Carter, Gregory; Chagas, Marcos H; Chan, Juliana C N; Cholera, Rushina; Conwell, Yeates; de Man-van Ginkel, Janneke M; Fann, Jesse R; Fischer, Felix H; Fung, Daniel; Gelaye, Bizu; Goodyear-Smith, Felicity; Greeno, Catherine G; Hall, Brian J; Harrison, Patricia A; Härter, Martin; Hegerl, Ulrich; Hides, Leanne; Hobfoll, Stevan E; Hudson, Marie; Hyphantis, Thomas; Inagaki, Masatoshi; Jetté, Nathalie; Khamseh, Mohammad E; Kiely, Kim M; Kwan, Yunxin; Lamers, Femke; Liu, Shen-Ing.
  • Wu Y; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
  • Levis B; Department of Psychiatry, McGill University, Montréal, Québec, Canada.
  • Riehm KE; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada.
  • Saadat N; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
  • Levis AW; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada.
  • Azar M; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
  • Rice DB; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
  • Boruff J; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
  • Cuijpers P; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
  • Gilbody S; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
  • Ioannidis JPA; Department of Psychology, McGill University, Montréal, Québec, Canada.
  • Kloda LA; Schulich Library of Physical Sciences, Life Sciences, and Engineering, McGill University, Montreal, Quebec, Canada.
  • McMillan D; Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit, Amsterdam, the Netherlands.
  • Patten SB; Hull York Medical School and the Department of Health Sciences, University of York, Heslington, York, UK.
  • Shrier I; Department of Medicine, Department of Health Research and Policy, Department of Biomedical Data Science, Department of Statistics, Stanford University, Stanford, California, USA.
  • Ziegelstein RC; Library, Concordia University, Montréal, Québec, Canada.
  • Akena DH; Hull York Medical School and the Department of Health Sciences, University of York, Heslington, York, UK.
  • Arroll B; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
  • Ayalon L; Hotchkiss Brain Institute and O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada.
  • Baradaran HR; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
  • Baron M; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada.
  • Bombardier CH; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Butterworth P; Department of Psychiatry, Makerere University College of Health Sciences, Kampala, Uganda.
  • Carter G; Department of General Practice and Primary Health Care, University of Auckland, Auckland, New Zealand.
  • Chagas MH; Louis and Gabi Weisfeld School of Social Work, Bar Ilan University, Ramat Gan, Israel.
  • Chan JCN; Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
  • Cholera R; Ageing Clinical & Experimental Research Team, Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, Scotland, UK.
  • Conwell Y; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
  • de Man-van Ginkel JM; Department of Medicine, McGill University, Montréal, Québec, Canada.
  • Fann JR; Department of Rehabilitation Medicine, University of Washington, Seattle, Washington, USA.
  • Fischer FH; Centre for Research on Ageing, Health and Wellbeing, Research School of Population Health, The Australian National University, Canberra, Australia.
  • Fung D; Melbourne Institute of Applied Economic and Social Research, University of Melbourne, Melbourne, Australia.
  • Gelaye B; Centre for Brain and Mental Health Research, University of Newcastle, New South Wales, Australia.
  • Goodyear-Smith F; Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Greeno CG; Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.
  • Hall BJ; Asia Diabetes Foundation, Prince of Wales Hospital, Hong Kong SAR, China.
  • Harrison PA; Hong Kong Institute of Diabetes and Obesity, Hong Kong SAR, China.
  • Härter M; Department of Pediatrics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Hegerl U; Department of Psychiatry, University of Rochester Medical Center, New York, USA.
  • Hides L; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Hobfoll SE; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA.
  • Hudson M; Department of Psychosomatic Medicine, Center for Internal Medicine and Dermatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Hyphantis T; Department of Child & Adolescent Psychiatry, Institute of Mental Health, Singapore, Singapore.
  • Inagaki M; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Jetté N; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Khamseh ME; Programme in Health Services & Systems Research, Duke-NUS Medical School, Singapore, Singapore.
  • Kiely KM; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Kwan Y; Department of General Practice and Primary Health Care, University of Auckland, Auckland, New Zealand.
  • Lamers F; School of Social Work, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Liu SI; Global and Community Mental Health Research Group, Department of Psychology, Faculty of Social Sciences, University of Macau, Macau Special Administrative Region, China.
Psychol Med ; 50(8): 1368-1380, 2020 06.
Article en En | MEDLINE | ID: mdl-31298180
BACKGROUND: Item 9 of the Patient Health Questionnaire-9 (PHQ-9) queries about thoughts of death and self-harm, but not suicidality. Although it is sometimes used to assess suicide risk, most positive responses are not associated with suicidality. The PHQ-8, which omits Item 9, is thus increasingly used in research. We assessed equivalency of total score correlations and the diagnostic accuracy to detect major depression of the PHQ-8 and PHQ-9. METHODS: We conducted an individual patient data meta-analysis. We fit bivariate random-effects models to assess diagnostic accuracy. RESULTS: 16 742 participants (2097 major depression cases) from 54 studies were included. The correlation between PHQ-8 and PHQ-9 scores was 0.996 (95% confidence interval 0.996 to 0.996). The standard cutoff score of 10 for the PHQ-9 maximized sensitivity + specificity for the PHQ-8 among studies that used a semi-structured diagnostic interview reference standard (N = 27). At cutoff 10, the PHQ-8 was less sensitive by 0.02 (-0.06 to 0.00) and more specific by 0.01 (0.00 to 0.01) among those studies (N = 27), with similar results for studies that used other types of interviews (N = 27). For all 54 primary studies combined, across all cutoffs, the PHQ-8 was less sensitive than the PHQ-9 by 0.00 to 0.05 (0.03 at cutoff 10), and specificity was within 0.01 for all cutoffs (0.00 to 0.01). CONCLUSIONS: PHQ-8 and PHQ-9 total scores were similar. Sensitivity may be minimally reduced with the PHQ-8, but specificity is similar.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tamizaje Masivo / Trastorno Depresivo Mayor / Cuestionario de Salud del Paciente Tipo de estudio: Diagnostic_studies / Prognostic_studies / Qualitative_research / Screening_studies / Systematic_reviews Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tamizaje Masivo / Trastorno Depresivo Mayor / Cuestionario de Salud del Paciente Tipo de estudio: Diagnostic_studies / Prognostic_studies / Qualitative_research / Screening_studies / Systematic_reviews Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article